The latest price target for Baxter Intl (NYSE:BAX) was reported by Barclays on March 10, 2025. The analyst firm set a price target for $41.00 expecting BAX to rise to within 12 months (a possible 12.14% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Baxter Intl (NYSE:BAX) was provided by Barclays, and Baxter Intl maintained their overweight rating.

There is no last upgrade for Baxter Intl

The last downgrade for Baxter International Inc happened on July 15, 2024 when Morgan Stanley changed their price target from $39 to $30 for Baxter International Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Baxter Intl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Baxter Intl was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.

While ratings are subjective and will change, the latest Baxter Intl (BAX) rating was a maintained with a price target of $39.00 to $41.00. The current price Baxter Intl (BAX) is trading at is $36.56, which is out of the analyst’s predicted range.